Search Results - "Cheung, Kit Wun Kathy"
-
1
Calibrating the In Vitro-In Vivo Correlation for OATP-Mediated Drug-Drug Interactions with Rosuvastatin Using Static and PBPK Models
Published in Drug metabolism and disposition (01-12-2020)“…Organic anion-transporting polypeptide (OATP) 1B1/3-mediated drug-drug interaction (DDI) potential is evaluated in vivo with rosuvastatin (RST) as a probe…”
Get full text
Journal Article -
2
Incorporating Ontogeny in Physiologically Based Pharmacokinetic Modeling to Improve Pediatric Drug Development: What We Know About Developmental Changes in Membrane Transporters
Published in Journal of clinical pharmacology (01-09-2019)“…Developmental changes in the biological processes involved in the disposition of drugs, such as membrane transporter expression and activity, may alter the…”
Get full text
Journal Article -
3
Assessment of cytochrome P450 3A4-mediated drug–drug interactions for ipatasertib using a fit-for-purpose physiologically based pharmacokinetic model
Published in Cancer chemotherapy and pharmacology (01-05-2022)“…Purpose Ipatasertib, a potent and highly selective small-molecule inhibitor of AKT, is currently under investigation for treatment of cancer. Ipatasertib is a…”
Get full text
Journal Article -
4
Advancing drug development in pediatric oncology, a focus on cancer biology and targeted therapies: iMATRIX platform
Published in Journal of biopharmaceutical statistics (02-11-2023)“…With the development of novel treatment therapies as well as evolving and innovative approaches to conduct clinical trials, the landscape of pediatric oncology…”
Get full text
Journal Article -
5
Unraveling the functional role of the orphan solute carrier, SLC22A24 in the transport of steroid conjugates through metabolomic and genome-wide association studies
Published in PLoS genetics (25-09-2019)“…Variation in steroid hormone levels has wide implications for health and disease. The genes encoding the proteins involved in steroid disposition represent key…”
Get full text
Journal Article -
6
Exploring the Impact of Hepatic Impairment on Pralsetinib Pharmacokinetics
Published in Pharmaceutics (01-04-2024)“…Pralsetinib is a kinase inhibitor indicated for the treatment of metastatic rearranged during transfection ( ) fusion-positive non-small cell lung cancer…”
Get full text
Journal Article -
7
-
8
Effect of Hepatic Impairment on Cobimetinib Pharmacokinetics: The Complex Interplay Between Physiological Changes and Drug Characteristics
Published in Clinical pharmacology in drug development (01-02-2021)“…Cobimetinib is a kinase inhibitor indicated for use in combination with vemurafenib for treatment of unresectable/metastatic melanoma with specific BRAF…”
Get full text
Journal Article -
9
Maximum likelihood estimation of renal transporter ontogeny profiles for pediatric PBPK modeling
Published in CPT: pharmacometrics and systems pharmacology (01-04-2024)“…Optimal treatment of infants with many renally cleared drugs must account for maturational differences in renal transporter (RT) activity. Pediatric…”
Get full text
Journal Article -
10
Evaluation of Ipatasertib Interactions with Itraconazole and Coproporphyrin I and III in a Single Drug Interaction Study in Healthy Subjects
Published in The Journal of pharmacology and experimental therapeutics (01-08-2021)“…Ipatasertib is a pan-AKT inhibitor in development for the treatment of cancer. Ipatasertib was metabolized by CYP3A4 to its major metabolite, M1 (G-037720),…”
Get full text
Journal Article -
11
GDC-0810 Pharmacokinetics and Transporter-Mediated Drug Interaction Evaluation with an Endogenous Biomarker in the First-in-Human, Dose Escalation Study
Published in Drug metabolism and disposition (01-09-2019)“…GDC-0810 (Cheeti et al., 2018) is an orally bioavailable, selective estrogen receptor (ER) degrader developed to treat ER-positive breast cancer. A…”
Get full text
Journal Article -
12
A Comprehensive Analysis of Ontogeny of Renal Drug Transporters: mRNA Analyses, Quantitative Proteomics, and Localization
Published in Clinical pharmacology and therapeutics (01-11-2019)“…Human renal membrane transporters play key roles in the disposition of renally cleared drugs and endogenous substrates, but their ontogeny is largely unknown…”
Get full text
Journal Article -
13
The Effect of Uremic Solutes on the Organic Cation Transporter 2
Published in Journal of pharmaceutical sciences (01-09-2017)“…Chronic kidney disease (CKD) is characterized by the accumulation of uremic solutes; however, little is known about how these solutes affect drug absorption…”
Get more information
Journal Article -
14
-
15
A Comprehensive Analysis of Ontogeny of Renal Drug Transporters: mRNA Analyses, Quantitative Proteomics, and Localization
Published in Clinical pharmacology and therapeutics (03-07-2019)“…Not provided…”
Get full text
Journal Article